|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date21 Oct 2019 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 Jul 2015 |
100 Clinical Results associated with Vertex Pharmaceuticals (Australia) Pty Ltd.
0 Patents (Medical) associated with Vertex Pharmaceuticals (Australia) Pty Ltd.
100 Deals associated with Vertex Pharmaceuticals (Australia) Pty Ltd.
100 Translational Medicine associated with Vertex Pharmaceuticals (Australia) Pty Ltd.